Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1999
12/29/1999EP0379483B1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES
12/29/1999CN1239962A 1,4-diazabicyclo [2,2,2] oct-2-ylmethyl derivatives, their preparation and therapeutic application
12/29/1999CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors
12/29/1999CN1239950A New derivates from piperidine-keto acid, their preparation and use
12/29/1999CN1239949A Novel heterocyclically substituted benzamides and their use in fighting diseases
12/29/1999CN1239944A New pentaerythritol derivatives, their production, and use and intermdiates for their synthesis
12/29/1999CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs.
12/29/1999CN1239888A Method for inhibiting stress-activated protein kinases
12/29/1999CN1239887A Pharmaceutical compositions containing N-sulphonyl indolin derivatives
12/29/1999CN1239666A Piles-treating medicated wine
12/29/1999CN1047778C Pyrimido [5,4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them
12/29/1999CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999CA2336192A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999CA2335799A1 Novel compounds derived from .alpha.-d-xylose, preparation method and therapeutic use
12/29/1999CA2335559A1 Arylsulfonanilide phosphates
12/29/1999CA2335545A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
12/29/1999CA2335366A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999CA2335356A1 Nitrate salts of antihypertensive medicines
12/29/1999CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones
12/29/1999CA2334973A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
12/29/1999CA2330175A1 Ependymal neural stem cells and method for their isolation
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/28/1999US6008336 Compacted nucleic acids and their delivery to cells
12/28/1999US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia
12/28/1999US6008245 Treatment of prophylaxis and cardiovascular disorders, in particular arrhythmias, for the treatment of ulcers of the gastrointestinal disorders, diarrheal diseases
12/28/1999US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues
12/28/1999US6008221 Method for treating Alzheimer's disease with folic acid
12/28/1999US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer
12/28/1999US6008211 Photoactivatable compounds comprising benzochlorin and furocoumarin
12/28/1999US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease
12/28/1999US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases
12/28/1999US6008039 Polynucleotide encoding a novel purinergic P2U receptor
12/28/1999US6008017 Human cardiac/brain tolloid-like protein
12/28/1999CA2155169C Process and compositions for activating the differentiation of preadipocyte cells and related therapeutic treatments
12/28/1999CA2009687C Organosiloxane-containing polysaccharides
12/28/1999CA1340866C Human c3b/c4b receptor (cr1)
12/28/1999CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066036A1 Transplants for myocardial scars
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065933A1 Novel cyclosporins
12/23/1999WO1999065922A2 Prenyl transferase inhibitors
12/23/1999WO1999065912A1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity
12/23/1999WO1999065898A1 Imidazolyl derivatives
12/23/1999WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065877A1 Therapeutic biaryl derivatives
12/23/1999WO1999065874A1 Benzanilide derivatives and medicinal compositions
12/23/1999WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065571A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors
12/23/1999WO1999065500A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
12/23/1999WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065310A1 Il-8 receptor antagonists
12/23/1999WO1999065306A1 Methods for reducing levels of homocysteine and c-reactive protein
12/23/1999DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999DE19827640A1 New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
12/23/1999DE19826843A1 Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Imidazotriazolopyrimidine new, processes for their preparation and their use as medicaments
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999CA2337603A1 Prenyl transferase inhibitors
12/23/1999CA2335435A1 Imidazolyl derivatives
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335292A1 Il-8 receptor antagonists
12/23/1999CA2335248A1 Transplants for myocardial scars
12/23/1999CA2335038A1 Combination of radiotherapy and anti-angiogenic factors
12/23/1999CA2333666A1 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2333384A1 Methods for reducing levels of homocysteine and c-reactive protein
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/22/1999EP0965341A2 Combination of dofetilide and a calcium channel blocker
12/22/1999EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999EP0964869A1 Methods and compositions for generating angiostatin
12/22/1999EP0964864A2 Pyrido 2,3-d] pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
12/22/1999EP0964860A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
12/22/1999EP0964856A1 Bicyclic amino acids
12/22/1999EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
12/22/1999EP0964692A1 Use of glp-1 or analogs in treatment of myocardial infarction
12/22/1999EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999EP0964679A1 Method for the treatment of neurological or neuropsychiatric disorders
12/22/1999EP0904077A4 Methods for the preparation of biphenyl isoxazole sulfonamides
12/22/1999EP0758312B1 Substituted fused and bridged bicyclic compounds as therapeutic agents
12/22/1999EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/22/1999EP0684953A4 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives.
12/22/1999EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF
12/22/1999CN1239433A Methods and compsns. for stimulating neurite growth using compounds with affinity for PKBP12 in combination with neurotrophic factors
12/22/1999CN1238980A Process for preparing medical 'Fenghegui' wine for preventing and curing apoplexy
12/21/1999US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists
12/21/1999US6005010 Cardiovascular disorders, antiarrhythmia agents and antiischemic agents
12/21/1999US6004989 Benzimidazole derivatives, their production and use
12/21/1999US6004988 Carboxylic acid derivatives, their preparation and their use
12/21/1999US6004987 Use of ligands which are specific for RXR receptors
12/21/1999US6004966 Use of xanthine oxidase inhibitors as anti-ischaemic agents
12/21/1999US6004965 Endothelin inhibitors; hypotensive agents; cardiovascular disorders
12/21/1999US6004963 Tumor necrosis factor release inhibitors; immunomodulators
1 ... 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 ... 1595